Most Read This Week
- Belzutifan vs Everolimus for Advanced Renal Cell Carcinoma
- Molecularly Guided Therapy vs Chemotherapy After Disease Control in Unfavourable Cancer of Unknown Primary
- Androgen Receptor Pathway Inhibitors and Taxanes for Metastatic Prostate Cancer
- Trastuzumab Deruxtecan in Patients With HER2-Positive Advanced Colorectal Cancer
- Acalabrutinib Plus Venetoclax and Rituximab for Treatment-Naïve Mantle Cell Lymphoma
Recently Updated
- Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
- Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years
- Palliative Low-Dose Radiotherapy Improves Pain in Hepatic Cancer
- Most Patients With Stage I PDAC Are Upstaged on Histopathology
- Psychological Illness, CVD Risk Increased for Relatives, Spouses of Cancer Patients